Business Context and Reporting Period
This Form 8-K filing by Alphatec Holdings, Inc. covers the event date of December 30, 2016. The report details the issuance of unregistered securities pursuant to a Collaboration Agreement dated October 22, 2013, as amended, between Alphatec Spine, Inc. (a wholly owned subsidiary) and the Collaborator (Elite Medical Holdings, LLC and Pac 3 Surgical Products, LLC).
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the issuance of 110,396 shares of common stock (par value $0.0001 per share) as non-cash compensation for consultation services related to product development activities during the third year of the Collaboration Agreement.
Material Changes
The material change reported is the increase in outstanding common stock by 110,396 shares. These shares were issued to 24 individuals and entities designated by the Collaborator. The transaction was executed under an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the unregistered issuance. The transaction is described as payment for services already rendered in connection with product development.
Investor Verification Checklist
- Verify the total number of shares issued (110,396) and the par value ($0.0001).
- Confirm the identity of the 24 recipients designated by the Collaborator.
- Review the terms of the Collaboration Agreement dated October 22, 2013, to understand the scope of product development activities.
- Assess the dilution impact of the 110,396 shares on existing shareholders.
- Confirm the validity of the Section 4(a)(2) exemption claim for this transaction.